WHO WE ARE
PNB Vesper Life Sciences Pvt. Ltd
PNB Vesper Life Sciences Pvt. Ltd is a research-based bio-pharmaceutical organization that is determined to discover drugs for serious diseases and unmet medical conditions. PNB Vesper is currently one of very few companies in India that is focused only on research-based NCEs, rather than generics.
The company based in Kochi, India was incorporated in the year 2011. The company’s promoters have been contracting its preclinical research and development activities with various reputed academic and commercial organizations in UK, US, Thailand, and India for the last 14 years (even before incorporating PNB Vesper Life Science in 2011).PNB Vesper’s products arise from five programs, cholecystokinin receptor (CCK) program that were under development for more than a decade.
PNB Vesper is actually ivolved in developing drugs for unmet medical needs.. PNB Vesper has synthezised hundreds of molecules and systematically characterized to select lead molecules. The lead molecules have the potential to treat variety of diseases including pain, cancer, inflammation such as inflammatory bowel disease (IBD), neurological diseases such as anxiety, depression, metabolic diseases, and others. PNB Vesper’s assets are well protected by intellectual property filings both in US and many other countries in the around the World, which will not expire until 2036.
The Company currently has 5 molecules under development, 3 (New Chemical Entities) NCE in preclinical phases, 2 molecules in clinical phases.
PNB Vesper is currently functioning as a semi-virtual organization with most of its clinical research, preclinical research, and development activities being conducted by various reputed academic and commercial organizations in the UK, US, Thailand, and India. PNB Vesper’s assets are well protected by intellectual property filings both in the US and many other countries around the World, which will not expire until 2036.